Infliximab to Treat Non-Infectious Scleritis

NCT00075075 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Scleritis

Interventions

DRUG: Infliximab

Sponsor

National Eye Institute (NEI)